Terms: = Germ cell tumor AND SMARCA4, hSNF2b, 6597, P51532, BRG1, SNF2L4, SNF2, SWI2, FLJ39786, BAF190, SNF2LB, SNF2-BETA, ENSG00000127616
151 results:
1. Deep-targeted gene sequencing reveals ARID1A mutation as an important driver of glioblastoma.
Xiao M; Cui X; Xu C; Xin L; Zhao J; Yang S; Hong B; Tan Y; Zhang J; Li X; Li J; Kang C; Fang C
CNS Neurosci Ther; 2024 Apr; 30(4):e14698. PubMed ID: 38600891
[TBL] [Abstract] [Full Text] [Related]
2. Exploration of genetic characterization in hyperprogressive disease after immunotherapy retreatment in a patient with LCNEC: A case report.
Zhang Y; Yang J; Shao T; Chen J; Shu Q; Shou L
Hum Vaccin Immunother; 2024 Dec; 20(1):2313281. PubMed ID: 38348622
[TBL] [Abstract] [Full Text] [Related]
3. Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed Glioblastoma.
Lim-Fat MJ; Iorgulescu JB; Rahman R; Bhave V; Muzikansky A; Woodward E; Whorral S; Allen M; Touat M; Li X; Xy G; Patel J; Gerstner ER; Kalpathy-Cramer J; Youssef G; Chukwueke U; McFaline-Figueroa JR; Nayak L; Lee EQ; Reardon DA; Beroukhim R; Huang RY; Bi WL; Ligon KL; Wen PY
Clin Cancer Res; 2024 Apr; 30(7):1327-1337. PubMed ID: 38252427
[TBL] [Abstract] [Full Text] [Related]
4. An in-silico analysis reveals further evidence of an aggressive subset of lung carcinoids sharing molecular features of high-grade neuroendocrine neoplasms.
Pelosi G; Melocchi V; Dama E; Hofman P; De Luca M; Albini A; Gemelli M; Ricotta R; Papotti M; La Rosa S; Uccella S; Harari S; Sonzogni A; Asiedu MK; Wigle DA; Bianchi F
Exp Mol Pathol; 2024 Feb; 135():104882. PubMed ID: 38237798
[TBL] [Abstract] [Full Text] [Related]
5. Characterization of a Preclinical In Vitro Model Derived from a smarca4-Mutated Sinonasal Teratocarcinosarcoma.
Lorenzo-Guerra SL; Codina-Martínez H; Suárez-Fernández L; Cabal VN; García-Marín R; Riobello C; Vivanco B; Blanco-Lorenzo V; Sánchez-Fernández P; López F; Llorente JL; Hermsen MA
Cells; 2023 Dec; 13(1):. PubMed ID: 38201285
[TBL] [Abstract] [Full Text] [Related]
6. Real-World comprehensive genomic profiling data for diagnostic clarity in pulmonary Large-cell neuroendocrine carcinoma.
Burns L; Tukachinsky H; Raskina K; Huang RSP; Schrock AB; Sands J; Kulke MH; Oxnard GR; Tapan U
Lung Cancer; 2024 Feb; 188():107454. PubMed ID: 38159439
[TBL] [Abstract] [Full Text] [Related]
7. Tazemetostat in the therapy of pediatric INI1-negative malignant rhabdoid tumors.
Vejmelkova K; Pokorna P; Noskova K; Faustmannova A; Drabova K; Pavelka Z; Bajciova V; Broz M; Tinka P; Jezova M; Palova H; Kren L; Valik D; Slaby O; Sterba J
Sci Rep; 2023 Dec; 13(1):21623. PubMed ID: 38062114
[TBL] [Abstract] [Full Text] [Related]
8. Knockdown of HNRNPM inhibits the progression of glioma through inducing ferroptosis.
Wang J; Luo X; Liu D
Cell Cycle; 2023 Oct; 22(20):2264-2279. PubMed ID: 38016815
[TBL] [Abstract] [Full Text] [Related]
9. SWI/SNF-deficient tumors of the central nervous system: An update.
Hasselblatt M; Kool M; Frühwald MC
Clin Neuropathol; 2024; 43(1):2-9. PubMed ID: 37969088
[TBL] [Abstract] [Full Text] [Related]
10. Synchronous T-lymphoblastic lymphoma and neuroblastoma in a 3-yr-old with novel germline
Tibout P; Livingston J; Kanwar N; Yuki KE; Shlien A; Ngan B; Irwin MS; Morgenstern DA; Hitzler J; Villani A; Cohen-Gogo S
Cold Spring Harb Mol Case Stud; 2023 Dec; 9(4):. PubMed ID: 37932047
[TBL] [Abstract] [Full Text] [Related]
11. Divergent Malignant Melanocytic Differentiation in Ovarian Endometrioid Adenocarcinoma With Aberrant β-Catenin Expression: A Case Expanding the Histologic Spectrum of β-Catenin Activated Gynecologic Neoplasia.
Xu J; Weisman PS
Int J Gynecol Pathol; 2024 May; 43(3):302-307. PubMed ID: 37922945
[TBL] [Abstract] [Full Text] [Related]
12. Super-enhancer-driven expression of BAHCC1 promotes melanoma cell proliferation and genome stability.
Berico P; Nogaret M; Cigrang M; Lallement A; Vand-Rajabpour F; Flores-Yanke A; Gambi G; Davidson G; Seno L; Obid J; Vokshi BH; Le Gras S; Mengus G; Ye T; Cordero CF; Dalmasso M; Compe E; Bertolotto C; Hernando E; Davidson I; Coin F
Cell Rep; 2023 Nov; 42(11):113363. PubMed ID: 37924516
[TBL] [Abstract] [Full Text] [Related]
13. MYC overexpression and smarca4 loss cooperate to drive medulloblastoma formation in mice.
Göbel C; Godbole S; Schoof M; Holdhof D; Kresbach C; Loose C; Neumann J; Schüller U
Acta Neuropathol Commun; 2023 Nov; 11(1):174. PubMed ID: 37919824
[TBL] [Abstract] [Full Text] [Related]
14. GAS41 promotes H2A.Z deposition through recognition of the N terminus of histone H3 by the YEATS domain.
Kikuchi M; Takase S; Konuma T; Noritsugu K; Sekine S; Ikegami T; Ito A; Umehara T
Proc Natl Acad Sci U S A; 2023 Oct; 120(43):e2304103120. PubMed ID: 37844223
[TBL] [Abstract] [Full Text] [Related]
15. Comparative Analysis of the Embryonal Brain tumors Based on Their Molecular Features.
Shcherbina V; Kovalevska L; Pedachenko E; Malysheva T; Kashuba E
Discov Med; 2023 Oct; 35(178):733-749. PubMed ID: 37811612
[TBL] [Abstract] [Full Text] [Related]
16. Next-generation bromodomain inhibitors of the SWI/SNF complex enhance DNA damage and cell death in glioblastoma.
Yang C; He Y; Wang Y; McKinnon PJ; Shahani V; Miller DD; Pfeffer LM
J Cell Mol Med; 2023 Sep; 27(18):2770-2781. PubMed ID: 37593885
[TBL] [Abstract] [Full Text] [Related]
17. PRAME immunohistochemistry in soft tissue tumors and mimics: a study of 350 cases highlighting its imperfect specificity but potentially useful diagnostic applications.
Cammareri C; Beltzung F; Michal M; Vanhersecke L; Coindre JM; Velasco V; Le Loarer F; Vergier B; Perret R
Virchows Arch; 2023 Aug; 483(2):145-156. PubMed ID: 37477762
[TBL] [Abstract] [Full Text] [Related]
18. Brain and Spinal Cord tumors of Embryonic Origin.
Lampros M; Alexiou GA
Adv Exp Med Biol; 2023; 1405():405-420. PubMed ID: 37452947
[TBL] [Abstract] [Full Text] [Related]
19. Recurrent atypical teratoid/rhabdoid tumors (AT/RT) reveal discrete features of progression on histology, epigenetics, copy number profiling, and transcriptomics.
Johann PD; Altendorf L; Efremova EM; Holsten T; Steinbügl M; Nemes K; Eckhardt A; Kresbach C; Bockmayr M; Koch A; Haberler C; Antonelli M; DeSisto J; Schuhmann MU; Hauser P; Siebert R; Bens S; Kool M; Green AL; Hasselblatt M; Frühwald MC; Schüller U
Acta Neuropathol; 2023 Sep; 146(3):527-541. PubMed ID: 37450044
[TBL] [Abstract] [Full Text] [Related]
20. The role of chromatin remodeler smarca4/brg1 in brain cancers: a potential therapeutic target.
Navickas SM; Giles KA; Brettingham-Moore KH; Taberlay PC
Oncogene; 2023 Jul; 42(31):2363-2373. PubMed ID: 37433987
[TBL] [Abstract] [Full Text] [Related]
[Next]
